None listed
Conditions
Brief summary
Gestational impaired glucose tolerance, associated with subsequent maternal non-insulin dependent diabetes, is routinely screened for during pregnancy, despite the lack of consensus as to the value of such screening and the subsequent management. Epidemiological studies suggest maternal and perinatal morbidity, often attributed to glucose intolerance in pregnancy, is more likely to be due to the effects of maternal age, maternal obesity or the knowledge of the diagnosis and the consequences of subsequent management. The aim of this multicentre study is to assess two forms of antenatal care in women with impaired glucose tolerance; routine antenatal care with 'diabetic style care'. The primary outcomes relate to important perinatal and maternal morbidity. The results will help answer the question as to whether substantial resources should be applied to the diagnosis and management of glucose intolerance in pregnancy. This trial assesses two forms of care for treating women with glucose intolerance of pregnancy.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Singleton or twin pregnancy with a positive Glucose Challenge Test (GCT) or risk factors for Gestational Diabetes Mellitus (GDM) at 16-30.0 weeks gestation and at 24-34.6 weeks gestation, an Oral Glucose Tolerance Test (OGTT) result: fasting <7.8mmol/L and 2 hour > or equal to 7.8mmol/L and < or equal to 11.0mmol/L.
Exclusion criteria
Previously treated Glucose Intolerance in Pregnancy or Gestational Diabetes, Chronic active systemic disease (excluding essential hypertension), Diabetes, Gestational Diabetes OGTT result (fasting > or equal to 7.8mmol/L and/or 2 hr > or equal to 11.1mmol/L), Glucose Intolerance in Pregnanct detected in current pregnancy before 20 weeks.